Medera Logo
Dr. Barry Borlaug
James Kim

James Kim

Chief Corporate Officer


Mr. Kim has served as the Company’s Chief Corporate Officer since March 2025. He has over 20 years of experience in the biopharmaceutical industry as a senior executive and an investment banker. In 2024, Mr. Kim was the Chief Financial Officer at TriArm Therapeutics, a private biotechnology company specializing in CAR-T therapies. Prior to his role at TriArm, Mr. Kim was a Managing Director at Stifel, Raymond James, Cantor Fitzgerald, and Jefferies, focused on biopharmaceutical coverage. He has advised on and executed over 100 transactions, totaling approximately $13 billion in mezzanine, public equity, and debt financings, as well as $12 billion in business development and M&A transactions.


Mr. Kim holds a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania.

Back to Management Team
Share by: